ARID3C: A Promising Drug Target and Biomarker (G138715)

Target Name: ARID3C

NCBI ID: G138715

ARID3C

ARID3C: A Promising Drug Target and Biomarker

Artificial Intelligence (AI) and Machine Learning (ML) have revolutionized the field of drug discovery, providing new tools for the prediction of potential drug targets and biomarkers. One of the promising areas of research is the use of AI-based models to identify and predict the interactivity domains (IDs) of proteins, which are involved in various cellular processes and drug responses. One of the IDs that has received a lot of attention in recent years is the At-rich interaction domain (ARID) 3C. In this article , we will explore the ARID3C protein and its potential as a drug target or biomarker.

The protein encoded by the ARID gene is a member of the At protein family, which plays a crucial role in various cellular processes, including cell signaling, protein-protein interactions, and DNA replication. The ARID protein has a unique structure that consists of a nucleotide-binding oligomerization domain (NBO), a nucleotide-binding domain (NBD), and a C-terminal T-helix domain.

The NBO is the protein's most distinctive feature, as it consists of a long extension that includes a core heptapeptide loop and several side chains that are involved in hydrogen bonding and other non-covalent interactions. The NBD is a parallel beta-sheet that includes a variable number of transmembrane helix subdomains. The C-terminal T-helix domain is responsible for the protein's stability and functions as a binding site for various ligands and drugs.

The ARID gene has been implicated in various cellular processes, including cell signaling, DNA replication, and cell division. It has been shown to be involved in the regulation of cell cycle progression, cell division, and apoptosis. The ARID protein has also been shown to play a role in the regulation of DNA replication, as it has been shown to interact with the DNA replication machinery.

The potential drug targets of ARID3C

The ARID protein has been shown to play a role in various cellular processes, making it an attractive drug target. One of the potential drug targets of ARID3C is cancer. Cancer is a disease that can be caused by the deregulation of various genes, including the ARID gene. Many studies have shown that the ARID protein is involved in the regulation of cancer cell growth, and that it has been implicated in the development and progression of various types of cancer.

The ARID protein has been shown to play a role in the regulation of cell proliferation, cell cycle progression, and apoptosis. It has been shown to interact with various cellular signaling pathways, including the PI3K/Akt signaling pathway, which is involved in the regulation of cell proliferation and survival.

Another potential drug target of ARID3C is neurodegenerative diseases. The ARID protein has been shown to play a role in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Many studies have shown that the ARID protein is involved in the regulation of neurodegenerative diseases. , and that it has been implicated in the development and progression of these diseases.

The ARID protein has also been shown to play a role in the regulation of diseases associated with protein misfolding, such as amyloidosis and neurofibrillary tangles. These diseases are characterized by the accumulation of misfolded proteins and the formation of aggregates that are involved in the development and progression of the diseases.

The potential biomarkers for ARID3C

The ARID protein has the potential to serve as a biomarker for various diseases, including cancer, neurodegenerative diseases, and diseases associated with protein misfolding. The ARID protein has been shown to play a role in the regulation of these diseases, and its levels or activity may be affected by various factors, including disease-specific conditions, medications, and environmental factors.

One of the potential biomarkers for ARID3C is the level of the ARID protein in various biological samples, such as blood, urine, or tissue. The level of the ARID protein may be affected by various factors, including disease severity, treatment, and age. By measuring the level

Protein Name: AT-rich Interaction Domain 3C

The "ARID3C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARID3C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets